| Document |
Document Title |
|
WO/2009/001367A2 |
The present invention relates to two novel and stable crystalline forms of atovaquone, to the processes for their preparation and to pharmaceutical compositions comprising them. The present invention also provides crystalline particles o...
|
|
WO/2008/139290A1 |
The invention concerns a new process for the preparation of naphthoquinones, in particular an improved process for the preparation of 2,3-disubstituted 1,4- naphthoquinones, in the trans configuration.
|
|
WO/2008/122988A1 |
Substantially pure atovaquone and parocess for the preparation thereof is disclosed.
|
|
WO/2008/111515A1 |
Disclosed is a simple and highly efficient process for producing an aromatic carbonyl compound, which can produce an aromatic carbonyl compound having a substituent introduced to an aromatic ring adjacent to a carbonyl group. The process...
|
|
WO/2008/107878A1 |
Novel cannabinoid-derived quinone derivatives (quinonoid derivatives) having a substituted hydroxyl group, pharmaceutical compositions comprising same and uses thereof as anti-proliferative agents, are provided.
|
|
WO/2008/108105A1 |
A specific quinone compound, which contains two quinone groups at ortho positions and has such a characteristic that an electron transfer is caused during a reversible oxidation-reduction reaction, is oligomerized or polymerized. Consequ...
|
|
WO/2007/125919A1 |
Disclosed is a sulfonated polymer having excellent workability and excellent methanol resistance. More specifically, disclosed is an aromatic compound represented by the general formula (1): (1) wherein A, D and E independently represent...
|
|
WO/2007/116750A1 |
Disclosed is a material for organic electroluminescent devices which contains a quinone derivative represented by one of the formulae (1)-(3) below. [In the formulae, R1-R16 respectively represent a hydrogen, a halogen, a cyano group, an...
|
|
WO/2007/104242A1 |
The invention has disclosed 1,2,3-trihydroxy benzene and its derivatives or pharmaceutically acceptable salts of formula I for zinc ion metal-protease inhibition. These compounds are used for selective depressants of zinc ion metal-prote...
|
|
WO/2007/078679A2 |
The present invention provides a convergent method for the synthesis of ubiquinones and ubiquinone analogues. Also provided are precursors of ubiquinones and their analogues that are useful in the methods of the invention. The invention ...
|
|
WO/2007/073651A1 |
Disclosed are 4,5-seco abieta diterpene quinones (i.e. saproorthoquinone derivatives) of formula A, B or C, physiological acceptable salts, preparation process and pharmaceutical compositions thereof , wherein in formula A, R1 is CH3, CH...
|
|
WO/2007/032378A1 |
A process for producing the compound represented by the following formula (1), which is menatetrenone. It is characterized in that a reaction solution consisting only of a solution obtained by dissolving the compound represented by the f...
|
|
WO/2007/026041A2 |
The invention relates to derivative 1,4-dioxaanthracene compounds, mainly 1,4-anthraquinoids, having formula I as tumour cell growth inhibitors. The invention also relates to methods of preparing said compounds, pharmaceutical compositio...
|
|
WO/2007/016762A1 |
The present invention relates to compounds which are perylenequinone derivatives, their stereoisomers and atropisomers. These compounds can be particularly useful as photosensitizers or sononsensitizers in photodynamic or sonodynamic the...
|
|
WO/2007/017168A1 |
A process for the preparation of ubihydroquinones and ubiquinones by condensation of a prenol or isoprenol with a hydroquinone or derivative thereof in the presence of 0.005 - 1.0 mol% of a catalyst which is a Broensted-acid, a Lewis-aci...
|
|
WO/2007/016635A2 |
The present invention relates to methods for purifying Coenzyme Q10.
|
|
WO/2006/132348A1 |
It is intended to provide a method of purifying ubiquinone-10 characterized by separating and removing a structural analog of ubiquinone-10 contained in a raw material liquid containing ubiquinone-10 by using an acrylic porous cross-link...
|
|
WO/2006/118167A1 |
[PROBLEMS] To provide a method, which can analyze environmental microorganisms in a simple and rapid manner, and an apparatus therefor. [MEANS FOR SOLVING PROBLEMS] An extractor for a quinone compound comprises an extraction vessel (9) i...
|
|
WO/2006/104970A1 |
Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantifi...
|
|
WO/2006/104411A1 |
The invention relates to a method for producing 2-methyl-1,4-naphthoquinone by oxidising a 2-methyl-1-naphthol with the aid of oxygen or oxygen-containing gas in an organic solvent medium or in a 2-methyl-1-naphthol melt and intensively ...
|
|
WO/2006/097472A2 |
The invention relates to novel methods of preventing, treating, or ameliorating medical conditions, including cancer, drug resistance, and parasite infections such as malaria, by administering compounds that are capable of inhibiting glu...
|
|
WO/2006/074521A1 |
The present invention provides a method of scavenging oxygen (particularly ground state oxygen) in an atmosphere or liquid comprising the steps of: (i) providing a polymeric composition comprising an hydrogenated anthraquinone derivative...
|
|
WO/2006/069658A1 |
The invention relates to a method for producing a pure or enriched Q10 coenzyme of formula (I) by separating a mixture containing the Q10 coenzyme and a compound of formula (II).
|
|
WO/2006/045548A2 |
The invention relates to a process for the preparation of p-methylenequinones of formula (I) wherein R1 and R2 are as defined in the description comprising the oxidative coupling of a compound of formula (V) followed by decarboxylation.
|
|
WO/2006/032425A2 |
The present invention relates to a practical and cost-effective method for the synthesis of 5-chloromethylated 2,3-dialkoxy-6-alkyl-1,4-benzoquinones by direct chloromethylation of the corresponding 2,3-dialkoxy-6-alkyl-1,4-benzoquinones...
|
|
WO/2006/024016A2 |
The present invention provides a new method of producing high quality idarubicin aglycone from 4-protected demethoxydaunomycinones such as 4-demethoxydaunomycinone-4-triflate.
|
|
WO/2006/008752A1 |
Novel crystalline forms of anti Pneumocystis carinii compound (2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoqui
none) commonly known as Atovaquone and methods for producing the same is disclosed herein. This also provides phar...
|
|
WO/2006/005530A1 |
The invention relates to a method for producing solanesylalkine by coupling suitable solanesyl derivatives to propargyl Grignard reagents. The invention also relates to the use of solanesylalkine produced in this way in order to produce ...
|
|
WO/2006/003395A2 |
A molten salt is described comprising a quinone or quinone derivative as anion or cation. A process for the production of hydrogen peroxide is also described comprising the steps of reducing the molten salt to produce a corresponding hyd...
|
|
WO/2005/097092A1 |
A new indication of use for bis(menadione bisulfite)piperazine (MBP) and a method for synthesizing the compound is described. MBP has a substantial vitamin K-like activity, which however, differently from other compounds currently in use...
|
|
WO/2005/092326A1 |
The present invention relates to naturally occurring and chemically synthesized small molecule antagonists of XIAP family proteins. In particular, the present invention provides embelin and other XIAP inhibitors and methods of using thes...
|
|
WO/2005/073158A1 |
The invention relates to compounds having general formula (I), wherein R1 and R2 represent, independently of each other, -OH, or -CH2-O-R3, or -CH2-S-R3, or formula (II), R3, R4, R5 and R6 representing, independently of each other, -H or...
|
|
WO/2005/067917A1 |
The present invention relates to cannabinoic quinone compounds, and especially to their medical use. In particular five cannabinoic quinones, designated HU-331, HU-336, HU-345, HU-395 and HU-396 are herein described as active agents in p...
|
|
WO/2005/068412A1 |
The present invention relates to novel ketone compounds, compositions comprising ketone compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders c...
|
|
WO/2005/056812A2 |
The present invention provides a convergent method for the synthesis of ubiquinones and ubiquinones analogues. Also provided are precursors of ubiquinones and their analogues that are useful in the methods of the invention, The invention...
|
|
WO/2005/042445A2 |
Fluorinated pentacene derivatives, e.g., tetradecafluoropentacene, 5,6,7,12,13,14-hexafluoropentacene, 5,7,12,14-tetrafluoropentacene, and 6,13-difluoropentacene, which are novel compounds, and intermediates therefor. Also provided are p...
|
|
WO/2005/035477A1 |
A method by which a compound having a quinone skeleton and coexistent with an antioxidant is stabilized; and a stabilized composition containing the compound having a quinone skeleton. The method of stabilizing a compound having a quinon...
|
|
WO/2005/034172A2 |
The invention relates to compositions for memory applications, a memory cell comprising said composition along with two electrodes, a method for producing microelectronic components, and the use of the inventive composition during the pr...
|
|
WO/2005/000259A1 |
The invention relates to the use of benzoquinones or their derivatives or salts as the single oxidation agent in substances for the oxidative treatment of hair and to substances containing at least one o-benzoquinone. The invention also ...
|
|
WO/2004/096742A1 |
The invention relates to the use of novel anthracene based compounds for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds.The invention relates more s...
|
|
WO/2004/093207A2 |
The invention relates to novel mixtures consisting of at least two substances, one substance being used as a matrix material and the other as a material which is capable of emission and contains at least one element having an atomic numb...
|
|
WO/2004/083336A2 |
The present invention provides functional finishing dyes comprising at least one functional finishing group covalently attached to a traditional dye via a chemical linkage. More particularly, the present invention provides novel antimicr...
|
|
WO/2004/075885A1 |
The invention relates to novel isotetracenone derivatives, medicaments which contain said derivatives or the salts thereof and the use of the isotetracenone derivatives in the treatment of diseases, especially helicobacter pylori infecti...
|
|
WO/2004/073699A1 |
Disclosed pharmaceuticals comprising shikonins or its salts , which are useful for curing and preventing microbial infection diseases, inflammation diseases, malignant tumor, hemorrhage and hemopathy, and immunoregulatory diseases.
|
|
WO/2004/018401A1 |
A method for producing biphenols by oxidative coupling of dialkylphenols which proceeds in two stages is disclosed, using a copper-amine complex which is catalytically active in each stage. A novel copper-amine complex is also disclosed ...
|
|
WO/2003/089576A2 |
Anthraquinones are described which have anticancer or antitumor activity and which are useful for inhibiting cancer cells and cells comprising tumors in vitro or in vivo. Preferably, the anthraquinones have the chemical formula (1), wher...
|
|
WO/2003/089577A2 |
Anthraquinones are described wnicn are antihelminthic and in particular, are useful in compositions for inhibiting Schistosoma sp. In vitro or in vivo. The preferred anthraquinones have the formula (I) wherein R1, R2, R3, and R4 are each...
|
|
WO/2003/066561A1 |
The invention concerns a compound of formula (I), wherein: R1 and R2, identical or different, represent each a hydrogen atom or an acyl or alkyl group; Ar represents an aryl or heteroaryl group; A represents a group selected from formula...
|
|
WO/2003/027050A2 |
A process for preparing substituted pentacene compounds comprises the step of cyclizing substituted bis(benzyl)phthalic acids using an acid composition comprising trifluoromethanesulfonic acid, the substituted bis(benzyl)phthalic acids b...
|
|
WO/2003/016407A1 |
The invention relates to new thioxanthone compounds having utility as fluorescent dyes and processes for their manufacture.
|
